Area-level geographic and socioeconomic factors and the local incidence of SARS-CoV-2 infections in Queensland between 2020 and 2022

被引:2
作者
Ward, Selina [1 ,2 ]
Restrepo, Angela Cadavid [1 ]
Mchugh, Lisa [1 ]
机构
[1] Univ Queensland, Sch Publ Hlth, Herston, Australia
[2] Univ Queensland Herston, Sch Publ Hlth, Herston Campus, Herston 4029, Australia
关键词
COVID-19; Queensland; epidemiology; spatial mapping; incidence;
D O I
10.1016/j.anzjph.2023.100094
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: Calculate the incidence of SARS-CoV-2 (COVID-19) infection notifications and the influence of area-level geographic and socioeconomic factors in Queensland using real-time data from the COVID-19 Real-time Information System for Preparedness and Epidemic Response (CRISPER) project.Design and setting: Population-level ecological study and spatial mapping of the incidence of COVID-19 infection notifications in Queensland, by postcode, 2020-2022. Main outcome measures: Proportions and distribution of COVID-19 infection notifications by year, age-group, socioeconomic disadvantage, and geospatial mapping. Incidence rate ratios (IRRs) were calculated.Results: Between 28 January 2020 and 30 June 2022, a total of 609,569 cases of COVID-19 associated with a Queensland postcode were recorded. The highest proportion of cases occurred in 2022 (96.5%), and in the 20-to 24-year age category (IRR = 1.787). In non-Major City areas, there was also a higher incidence of COVID-19 cases in lower socioeconomic areas (IRR = 0.84) than in higher socioeconomic areas (IRR = 0.66). Conclusions: Queensland experienced its highest proportion of COVID-19 cases once domestic and international borders opened. However, geographic and socioeconomic factors may have still contributed to a higher incidence of COVID-19 cases across some Queensland areas. Implications for Public Health: Although Australia has moved from the emergency response phase of the COVID-19 pandemic, we need to ensure ongoing prevention strategies target groups and areas that we have identified with the highest incidence.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Risk of Reinfection and Incidence of Chronic Symptoms After SARS-CoV-2 Infections
    Golding, Liam
    Watts, Allison W.
    Pitblado, Mark
    Clemens, Felicity
    Vineta Paramo, Marina
    Shew, Jacob
    Irvine, Michael A.
    Abu-Raya, Bahaa
    Goldfarb, David M.
    Masse, Louise C.
    Lavoie, Pascal M.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (10):
  • [22] Incidence and Severity of SARS-CoV-2 Infections in People With Primary Ciliary Dyskinesia
    Pedersen, Eva S. L.
    Schreck, Leonie D.
    Goutaki, Myrofora
    Bellu, Sara
    Copeland, Fiona
    Lucas, Jane S.
    Zwahlen, Marcel
    Kuehni, Claudia E.
    INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2023, 68
  • [23] SARS-CoV-2 Breakthrough Infections: Incidence and Risk Factors in a Large European Multicentric Cohort of Health Workers
    Porru, Stefano
    Monaco, Maria Grazia Lourdes
    Spiteri, Gianluca
    Carta, Angela
    Pezzani, Maria Diletta
    Lippi, Giuseppe
    Gibellini, Davide
    Tacconelli, Evelina
    Dalla Vecchia, Ilaria
    Sala, Emma
    Sansone, Emanuele
    De Palma, Giuseppe
    Bonfanti, Carlo
    Lombardo, Massimo
    Terlenghi, Luigina
    Pira, Enrico
    Mansour, Ihab
    Coggiola, Maurizio
    Ciocan, Catalina
    Godono, Alessandro
    Tardon, Adonina
    Rodriguez-Suarez, Marta-Maria
    Fernandez-Tardon, Guillermo
    Jimeno-Demuth, Francisco-Jose
    Castro-Delgado, Rafael-Vicente
    Iglesias Cabo, Tania
    Scapellato, Maria Luisa
    Liviero, Filippo
    Moretto, Angelo
    Mason, Paola
    Pavanello, Sofia
    Volpin, Anna
    Vimercati, Luigi
    Tafuri, Silvio
    De Maria, Luigi
    Sponselli, Stefania
    Stefanizzi, Pasquale
    Caputi, Antonio
    Gobba, Fabriziomaria
    Modenese, Alberto
    Casolari, Loretta
    Garavini, Denise
    D'Elia, Cristiana
    Mariani, Stefania
    Filon, Francesca Larese
    Cegolon, Luca
    Negro, Corrado
    Ronchese, Federico
    Rui, Francesca
    De Michieli, Paola
    VACCINES, 2022, 10 (08)
  • [24] Incidence of SARS-CoV-2 Infection and Related Mortality by Education Level during Three Phases of the 2020 Pandemic: A Population-Based Cohort Study in Rome
    Angelici, Laura
    Sorge, Chiara
    Di Martino, Mirko
    Cappai, Giovanna
    Stafoggia, Massimo
    Agabiti, Nera
    Girardi, Enrico
    Lanini, Simone
    Nicastri, Emanuele
    Davoli, Marina
    Cesaroni, Giulia
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (03)
  • [25] Epidemiology of healthcare-associated SARS-CoV-2 outbreaks in Germany between March 2020 and May 2022
    Suwono, B.
    Brandl, M.
    Hecht, J.
    Eckmanns, T.
    Haller, S.
    JOURNAL OF HOSPITAL INFECTION, 2023, 134 : 108 - 120
  • [26] SARS-CoV-2 Infection in Children Less Than Forty Days Hospitalized in Belgium Between 2020 and 2022
    Demey, Milena
    Bruyneel, Arnaud
    Chatzis, Olga
    Christiaens, Christelle
    Cossey, Veerle
    De Crombrugghe, Gabrielle
    De Lille, Lieve
    Goetghebuer, Tessa
    Gueulette, Emmanuelle
    Hainaut, Marc
    Heijmans, Catherine
    Hubinont, Hortense
    Le, Phu-Quoc
    Lecomte, Laurie
    Mattijs, Inge
    Mignon, Celine
    Mondovits, Benedicte
    Rodesch, Marine
    Rooze, Shancy
    Schelstraete, Petra
    Stroobant, Diane
    Thielemans, Laurence
    Thomas, Ingrid
    Valbona, Selimaj K.
    Van Damme, Emmi
    Van der Linden, Dimitri
    Van Praet, Jens
    Vermeulen, Francoise
    Weynants, David
    Tilmanne, Anne
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2024, 43 (09) : e307 - e309
  • [27] Interaction between hepatitis B virus and SARS-CoV-2 infections
    Xiang, Tian-Dan
    Zheng, Xin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (09) : 782 - 793
  • [28] An overview of SARS-CoV-2 variants circulating in the 2020-2022 period in Lombardy
    Giardina, Federica
    Ferrari, Guglielmo
    Zavaglio, Federica
    Paolucci, Stefania
    Rovida, Francesca
    Campanini, Giulia
    Pellegrinelli, Laura
    Galli, Cristina
    Pariani, Elena
    Bergami, Federica
    Nava, Alice
    Matarazzo, Elisa
    Renica, Silvia
    Fanti, Diana
    Cento, Valeria
    Alteri, Claudia
    Scaglione, Francesco
    Vismara, Chiara
    Perno, Carlo Federico
    Piralla, Antonio
    Baldanti, Fausto
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2023, 107 (04)
  • [29] Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020-2022
    Solastie, Anna
    Nieminen, Tuomo
    Ekstrom, Nina
    Nohynek, Hanna
    Lehtonen, Lasse
    Palmu, Arto A.
    Melin, Merit
    EMERGING MICROBES & INFECTIONS, 2023, 12 (02)
  • [30] The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022
    Pang, Xiaojing
    Liu, Yang
    Li, Hua
    Chen, Lixia
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 257